Home › Mga Kondisyon ng Balat › Illinois
Pag-aaral pangklinika para sa Mga Kondisyon ng Balat sa Illinois
7 pag-aaral para sa Mga Kondisyon ng Balat ang naghahanap ng mga kalahok sa mga site sa Illinois.
Mga Lungsod sa Illinois
Opisyal na teksto ng pag-aaral (English)
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
- Arlington Dermatology, Rolling Meadows
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07144345A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- Northwestern University, Chicago
- Northshore University Healthsystem, Skokie
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05723198Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
- Arlington Dermatology, Rolling Meadows
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07144852A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Endeavor Health, Skokie
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599813A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
- NU Dermatolgy CTU, Chicago
Nagre-recruitPhase 2
Edad 2 pataas · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07027345A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 2, Rolling Meadows
Nagre-recruitPhase 2
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT07037901Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Nagre-recruitMaagang Phase 1
6 Months · Lahat ng kasarian · Na-update May 1, 2026 · NCT05649098Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.